empower tirzepatide dosage Announcing semaglutide and PRICE DROP! We are excited to announce that our prices with Pharmacy are going DOWN for semaglutide and tirzepatide. Starting April 1st, we will be changing some Great news! Tirzepatide ODT is

February 2, 2026: FDA Posts Updated Safety Label for Mounjaro On January 20, 2026, the FDA posted an updated safety/warning label with new patient information for those taking Mounjaro (tirzepatide)

Practitioners interested in the evolving role of peptides in aesthetic medicine are encouraged to explore the Peptide Therapy Training at HubMed Ed for deeper clinical insight and patient protocol design

For many people, this is the correct therapeutic dose that produces optimal results with manageable side effects

GLP-1 drugs slow gastric emptying and reduce appetite, potentially triggering nausea, constipation, or abdominal painsymptoms that can be difficult to distinguish from disease flares

Key Points Not all GLP-1s are equal: tirzepatide has label-based guidance to use non-oral contraception or backup contraception for 4 weeks after starting and after each dose increase dose